Publicaciones en colaboración con investigadores/as de Hospital de Galdakao - Usansolo (21)

2023

  1. Impact of severe lymphopenia on the early prediction of clinical outcome in hospitalized patients with pneumococcal community-acquired pneumonia

    Infection, Vol. 51, Núm. 5, pp. 1319-1327

  2. Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?

    Frontiers in Medicine, Vol. 10

  3. Leukocyte differential and cell population data in the evaluation of SARS-CoV-2 and other infections

    Journal of Laboratory and Precision Medicine, Vol. 8

2022

  1. Comparison of the prognostic performance of the CURB-65 and a modified version of the pneumonia severity index designed to identify high-risk patients using the International Community-Acquired Pneumonia Collaboration Cohort

    Respiratory Medicine, Vol. 200

  2. Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study

    Revista Clinica Espanola, Vol. 222, Núm. 1, pp. 22-30

  3. Utility of Differential White Cell Count and Cell Population Data for Ruling Out COVID-19 Infection in Patients With Community-Acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 58, Núm. 12, pp. 802-808

2021

  1. Correction to: Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia (BMC Pulmonary Medicine, (2020), 20, 1, (261), 10.1186/s12890-020-01293-6)

    BMC Pulmonary Medicine

2020

  1. Early and Late Cardiovascular Events in Patients Hospitalized for Community-Acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 56, Núm. 9, pp. 551-558

  2. Non-bacteremic pneumococcal pneumonia: general characteristics and early predictive factors for poor outcome

    Infectious Diseases, Vol. 52, Núm. 9, pp. 603-611

  3. Q Fever (Coxiella Burnetii)

    Seminars in Respiratory and Critical Care Medicine, Vol. 41, Núm. 4, pp. 509-521

2019

  1. COPD classification models and mortality prediction capacity

    International Journal of COPD, Vol. 14, pp. 605-613

  2. Factors influencing long-term survival after hospitalization with pneumococcal pneumonia

    Journal of Infection, Vol. 79, Núm. 6, pp. 542-549

2018

  1. Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis

    Respiration, Vol. 96, Núm. 5, pp. 406-416

  2. Long-term Mortality in Community-acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 54, Núm. 8, pp. 412-413

  3. Screening for Latent Tuberculosis Infection in Patients who are Candidate for Biological Therapies in Spain? A Multidisciplinary Survey

    Archivos de Bronconeumologia, Vol. 54, Núm. 10, pp. 510-517

2017

  1. Validation of IDSA/ATS Algorithm for Duration of Pneumonia Therapy-Reply

    JAMA Internal Medicine

2016

  1. Chronic obstructive pulmonary disease subtypes. transitions over time

    PLoS ONE, Vol. 11, Núm. 9

2015

  1. Duration of Antibiotic Treatment in Community-Acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 51, Núm. 12, pp. 613-614

  2. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia

    Journal of Infection, Vol. 70, Núm. 5, pp. 457-466

2013

  1. Neumonitis por hipersensibilidad a isocianatos. Características clínico-radiológicas y de función pulmonar

    Archivos de Bronconeumologia, Vol. 49, Núm. 4, pp. 169-172